about
Human neuroma contains increased levels of semaphorin 3A, which surrounds nerve fibers and reduces neurite extension in vitroDifferential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerveThe semiology of tilt-induced psychogenic pseudosyncopeThe semiology of tilt-induced reflex syncope in relation to electroencephalographic changes.Differential activation of intestinal gene promoters: functional interactions between GATA-5 and HNF-1 alpha.A microscope for subtle movements in clinical neurology.The application of viral vectors to enhance regeneration after peripheral nerve repair.ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.From microsurgery to nanosurgery: how viral vectors may help repair the peripheral nerve.Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature.Nerve surgery and gene therapy: a neurobiological and clinical perspective.Gene therapy approaches to enhance regeneration of the injured peripheral nerve.Managing psychogenic pseudosyncope: Facts and experiences.Gene therapy and peripheral nerve repair: a perspective.Clinical and neurobiological advances in promoting regeneration of the ventral root avulsion lesion.Gene delivery to rat and human Schwann cells and nerve segments: a comparison of AAV 1-9 and lentiviral vectors.A comparative morphological, electrophysiological and functional analysis of axon regeneration through peripheral nerve autografts genetically modified to overexpress BDNF, CNTF, GDNF, NGF, NT3 or VEGF.Activity limitations in myasthenia gravis and relation to clinical variables.A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbar ventral root avulsion and implantation.The Tinel sign has no diagnostic value for nerve entrapment or neuropathy in the legs.Decompressive Surgery for Diabetic Neuropathy: Waiting for Incontrovertible Proof.Outcome of Carpal Tunnel Release and the Relation With Depression.The prevalence of 'Clinical Neurophysiology' and related terms in the English literature: A specialty in transition.Distinct representation of muscle weakness in QMG and MG-ADL.Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy.Creating dynamic virtual quarantines using "Pokémon Go" to limit infectious diseases spread.Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.Human Neuroma-in-Continuity Contains Focal Deficits in Myelination.Clinical Reasoning: Heart to swallow.In Reply: Decompressive Surgery for Diabetic Neuropathy: Waiting for Incontrovertible Proof.Clinical correlates of quantitative EEG in Parkinson disease: A systematic reviewQuantitative EEG reflects non-dopaminergic disease severity in Parkinson’s diseaseA systematic review of MEG-based studies in Parkinson's disease: The motor system and beyondSerologic prevalence of antibodies to Helicobacter pylori in internationally adopted childrenFatal ischemic stroke in a patient receiving lenalidomide for multiple myelomaThe terminology of psychogenic nonepileptic seizures: a historical perspectiveReply: Syncope and electroencephalographyVideo-EEG during tilt-table testing is an invaluable aid for understanding syncopeEmerging therapies for autoimmune myasthenia gravis: Towards treatment without corticosteroidsRepetitive ocular vestibular evoked myogenic potentials in myasthenia gravis
P50
Q28262871-B94C666E-B189-499D-BADC-9D49EF3A786DQ28577778-460151A5-0538-432C-8616-93ACCD9B6D7DQ33163063-61554926-7AE2-4BD5-9363-5F092326E3C0Q33163631-CF70B5B8-2E34-42A5-8C5B-C537D5BE6BDAQ33951590-543FE5BB-3443-476F-B5A0-E307DEC0F603Q35766273-5CEAE3F2-6C14-4248-807E-0805609607DDQ37350126-B334298B-506C-47CC-8743-9AEE143C8C9BQ37446047-9E03657D-53D5-453A-B70A-7155DC3F09C2Q37574414-8B7F29DC-FDC9-4A77-93CF-54B0FA2E58A9Q37728446-E007D6D5-6458-456E-88A2-C13620A74966Q37931558-CAAAAA41-B797-462B-B65D-3FC95A1EEAC6Q38122971-35D9D152-E7C4-408C-85A1-883A78AF584DQ38258435-35FA600A-3CAA-492B-AD12-7E96C780956EQ38559511-6C91F71A-350E-461E-8474-3E79CB6FC69BQ38594655-3FD3DDD3-5FA0-45D7-B9CF-7B0F4240DF02Q39011240-BEAA83FB-3147-472F-9044-39C5190ECAA5Q39144330-CD3B3CFE-D9E0-43F7-85BB-8F85B4581EBAQ39177532-C04EB176-16D7-46EE-9BD3-C261CE7837F5Q39818353-F4C8211E-7F73-4614-AD42-958A65326D87Q40263877-30D0017A-CDBD-4B4D-9801-203A43A41B02Q47628679-0BC59C1F-9440-4F40-BBDF-F55F6C10F41FQ47757582-30F6317B-101D-45A1-930F-A7D435466907Q48039412-5BFF445C-9663-4550-9F81-5CFC879D1AA9Q49920083-29CEE655-441D-4228-ACAE-7F7C1351E876Q51733350-5782E96F-9198-4C7B-BC8B-3DA561D1480CQ52263947-1FF0EE02-6915-44C7-BF85-325316E83AC3Q52772743-52721287-274E-433F-8A55-07967C71E7ABQ53401126-525AF7A7-C991-45D0-9FE0-E2EA2880EE4BQ54102796-369F5741-E0E6-4368-A11B-6F05BD2ED8F7Q54664542-5C19D18A-9A6B-4F75-ADE4-A7F1DEA9FBFBQ57022805-82253FA5-31F8-4BDD-A2B7-765F85B59566Q60728583-BBB8D49B-D02C-405E-B684-A833F3BEF052Q64777205-CA89EB7A-834C-4A9A-955F-E63DF322F380Q73405640-0256BC5D-F44C-435B-80BC-991D25F47178Q83398818-C94D06F4-A1CE-43B5-99F4-06E609B9AAC2Q85289801-12D145BA-BBAB-4EEC-9390-576FFFA44D20Q87688990-4DA4614E-250D-4824-9CF0-09E87813DF56Q88536741-8BB1EE01-C993-42CF-B8F6-A29EA039D438Q89481956-5CB39F52-64E8-44C3-BA86-E8B8D224C02AQ90690271-49721E83-908F-46D6-82CF-C9493399767D
P50
description
researcher
@en
name
Martijn Tannemaat
@en
Martijn Tannemaat
@nl
type
label
Martijn Tannemaat
@en
Martijn Tannemaat
@nl
prefLabel
Martijn Tannemaat
@en
Martijn Tannemaat
@nl
P106
P31
P496
0000-0003-2929-0390